Medline Inc. Class A common stock

$37.07$-0.77 (-2.03%)
Last updated on --.

Medline Inc. Class A common stock price

24 Hours-2.03%-$0.77
30 days+6.28%+$2.190
60 days+7.67%+$2.640
90 days+6.83%+$2.370

About Medline Inc. Class A common stock

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

Stock ticker
MDLN
Company
Medline Inc.
Industry
Healthcare
Category
US
Stock split / reverse split
--
Launch date
Dec 17, 2025
Listed exchange
NASDAQ

Financials

Q3 FY2026 Earnings
Report period: Jun 28, 2026 – Sep 26, 2026

Summary: MDLN reported Revenue of 7.86B (+10.41%), beating expectations; EPS of 0.44 (+41.94%), beating expectations.

Revenue (USD)Beat7.86B+10.41%7.72B--134.03M+1.73%
EPS (USD)Beat0.44+41.93%0.34--0.10+28.20%
Financial estimates
● Actual● Estimate
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
0.410.220.160.070.22
+0.00%---60.00%-83.34%-46.35%
● EPS● YoY
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
36.88B38.48B39.01B39.35B40.18B
19.74B19.20B19.67B20.27B20.79B
53.52%49.88%50.40%51.51%51.74%
● Assets● Liabilities● Ratio
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
636.00M229.00M412.00M715.00M1.03B
-11.92%---39.59%+262.94%+61.16%
● CFO● YoY

Shareholders

Shareholders
Mozart Holdco, Inc.26.57%
CARLYLE GROUP INC.21.83%
TC Group VII S1, L.L.C.16.43%
Mozart Aggregator II LP16.26%
H&F CORPORATE INVESTORS X, LTD.8.27%
Others10.62%
Institutions
% Owned91.87%+14.13%
Shares held752.48M+115.81M
Institutions423+95
% OwnedPrice
Name% OwnedChange
Mozart Holdco, Inc.26.57%--
CARLYLE GROUP INC.21.83%0.00
TC Group VII S1, L.L.C.16.43%--
Mozart Aggregator II LP16.26%--
H&F CORPORATE INVESTORS X, LTD.8.27%-15.60M

Medline Inc. Class A common stock conversion tables

MDLNMDLN
USDUSD
0.5 MDLN18.53 USD
1 MDLN37.07 USD
5 MDLN185.35 USD
10 MDLN370.7 USD
USDUSD
MDLNMDLN
0.5 USD0.013488 MDLN
1 USD0.026976 MDLN
5 USD0.13488 MDLN
10 USD0.26976 MDLN

More to explore

FAQ

MDLN is trading at $37.07, -2.03% over the last 24 hours. Track live moves on the price chart at the top of this page.

The MDLN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. MDLN is currently trading at $37.07, -2.03% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on MDLN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.

P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. MDLN's P/E ratio is currently 55.28 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from MDLN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against MDLN's historical range and other companies in the Healthcare sector.

Medline Inc.'s market cap is currently 32.55B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.